Grant Pickering

Insider Reports History

Entity
Individual
Location
C/O Vaxcyte, Inc., 825 Industrial Road, Ste. 300, San Carlos, California
Signature
Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Grant Pickering:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vaxcyte, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 465K $51.2M $110.15 Sep 3, 2024 Direct
Vaxcyte, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 142K $15.7M $110.15 Sep 3, 2024 By Children's Trust
Vaxcyte, Inc. CHIEF EXECUTIVE OFFICER, Director Stock Option (right to buy) 167K Aug 23, 2024 Direct
Athira Pharma, Inc. Director Stock Option (Right to Buy) 20.9K May 24, 2024 Direct

Insider Reports Filed by Grant Pickering

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCVX Vaxcyte, Inc. Sep 3, 2024 1 -$1.51M 4 Sep 5, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Aug 23, 2024 4 -$1.15M 4 Aug 26, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Aug 1, 2024 2 -$206K 4 Aug 5, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Jul 23, 2024 4 -$1.23M 4 Jul 24, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Jul 1, 2024 4 -$200K 4 Jul 2, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Jun 24, 2024 5 -$1.1M 4 Jun 25, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Jun 3, 2024 6 -$189K 4 Jun 5, 2024 CHIEF EXECUTIVE OFFICER, Director
ATHA Athira Pharma, Inc. May 24, 2024 1 $0 4 May 24, 2024 Director
PCVX Vaxcyte, Inc. May 23, 2024 4 -$1.01M 4 May 28, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. May 1, 2024 6 -$161K 4 May 3, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Apr 23, 2024 3 -$902K 4 Apr 25, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Apr 1, 2024 5 -$175K 4 Apr 3, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Mar 25, 2024 4 -$977K 4 Mar 27, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Mar 11, 2024 2 $132K 4 Mar 13, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Feb 29, 2024 9 -$763K 4 Mar 4, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Feb 23, 2024 9 -$3.43M 4 Feb 27, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Jan 29, 2024 3 -$1.93M 4 Jan 31, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Jan 23, 2024 7 -$937K 4 Jan 25, 2024 CHIEF EXECUTIVE OFFICER, Director
PCVX Vaxcyte, Inc. Jan 2, 2024 6 -$167K 4 Jan 4, 2024 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Dec 22, 2023 6 -$905K 4 Dec 27, 2023 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Dec 1, 2023 4 -$136K 4 Dec 5, 2023 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Nov 24, 2023 2 -$736K 4 Nov 28, 2023 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Nov 1, 2023 4 -$124K 4 Nov 3, 2023 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Oct 23, 2023 2 -$706K 4 Oct 25, 2023 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Oct 2, 2023 6 -$132K 4 Oct 4, 2023 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Sep 25, 2023 3 -$924K 4 Sep 27, 2023 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Sep 5, 2023 1 -$529K 4 Sep 6, 2023 Chief Executive Officer, Director
ATHA Athira Pharma, Inc. May 19, 2023 1 $0 4 May 22, 2023 Director
ATHA Athira Pharma, Inc. Mar 29, 2023 2 $60.4K 4 Mar 31, 2023 Director
PCVX Vaxcyte, Inc. Mar 1, 2023 3 -$129K 4 Mar 3, 2023 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Dec 30, 2022 3 $30.8K 4 Jan 4, 2023 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Sep 26, 2022 0 $0 4/A Sep 30, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Sep 15, 2022 1 -$307K 4 Sep 19, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Sep 2, 2022 1 -$235K 4 Sep 7, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Aug 26, 2022 4 -$274K 4 Aug 30, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Aug 15, 2022 2 -$281K 4 Aug 17, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Jul 26, 2022 2 -$233K 4 Jul 28, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Jul 15, 2022 2 -$269K 4 Jul 19, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Jun 24, 2022 2 -$226K 4 Jun 28, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Jun 21, 2022 3 -$216K 4 Jun 23, 2022 Chief Executive Officer, Director
ATHA Athira Pharma, Inc. May 20, 2022 1 $0 4 May 27, 2022 Director
PCVX Vaxcyte, Inc. May 16, 2022 4 -$243K 4 May 18, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Apr 18, 2022 3 -$244K 4 Apr 20, 2022 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Mar 21, 2022 7 -$507K 4 Mar 23, 2022 Chief Executive Officer, Director
ATHA Athira Pharma, Inc. Mar 21, 2022 0 $0 3/A Mar 21, 2022 Director
PCVX Vaxcyte, Inc. Mar 2, 2022 2 $0 4 Mar 4, 2022 Chief Executive Officer, Director
ATHA Athira Pharma, Inc. Jan 27, 2022 1 $0 4 Jan 31, 2022 Director
ATHA Athira Pharma, Inc. Jan 27, 2022 0 $0 3 Jan 31, 2022 Director
PCVX Vaxcyte, Inc. Dec 27, 2021 4 $93K 4 Dec 28, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Nov 19, 2021 4 -$325K 4 Nov 23, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Oct 20, 2021 4 -$312K 4 Oct 22, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Sep 21, 2021 7 -$351K 4 Sep 23, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Aug 23, 2021 4 -$286K 4 Aug 25, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Aug 19, 2021 3 -$27.4K 4 Aug 20, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Jul 20, 2021 3 -$316K 4 Jul 22, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Jun 24, 2021 4 -$295K 4 Jun 28, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Jun 21, 2021 6 -$23K 4 Jun 23, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Jun 3, 2021 6 -$307K 4 Jun 7, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. May 27, 2021 6 -$303K 4 May 28, 2021 Chief Executive Officer, Director
PCVX Vaxcyte, Inc. Feb 1, 2013 8 -$193K 4 Feb 5, 2024 CHIEF EXECUTIVE OFFICER, Director